SRT501
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SRT501, covering 2017-06-14 to 2019-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma [Phase 2]